Federation Des Caisses Desjardins Du Quebec Acelrx Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024
SELL
$1.78 - $2.59 $3,738 - $5,439
-2,100 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$0.28 - $0.61 $588 - $1,281
2,100 New
2,100 $601,000
Q2 2021

Aug 30, 2024
BUY
$1.03 - $1.7 $2,163 - $3,570
2,100 New
2,100 $2.9 Million
Q1 2021

Aug 30, 2024
BUY
$1.25 - $2.77 $2,625 - $5,817
2,100 New
2,100 $3.57 Million

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email